Tag: causes of death

We Were Wrong To Panic About Secondhand Smoke

In 2003, UCLA epidemiologist James Enstrom and I published a study of environmental tobacco smoke (ETS)—also called “secondhand smoke” or “passive smoking”—in the British Medical Journal (BMJ). Using data from the American Cancer Society’s prospective study of 1 million adults, we concluded that ETS exposure was not associated with increased mortality.

Since that conclusion flew in the face of the conventional wisdom that had long driven state and local bans on smoking in public places, our study understandably sparked a controversy in the public health community. But the intensity of the attack on us in the pages of a medical journal—by critics who were certain that our study had to be wrong but typically failed to provide specific evidence of fatal errors—vividly illustrates what can happen when policy preferences that have taken on the status of doctrine override rational scientific debate.

A recent study by American Cancer Society (ACS) researchers underscores that point by showing that, contrary to what our critics asserted, the cancer risk posed by ETS is likely negligible. The authors present that striking result without remarking on it, which may reflect their reluctance to revisit a debate that anti-smoking activists and public health officials wrongly view as long settled.

Exposure to ETS is known to cause eye and throat irritation and to exacerbate preexisting respiratory conditions. In addition, it is simply disagreeable to many people (including me). But assessing the claim that ETS is potentially deadly requires dispassionate examination of the available scientific evidence.

That is not what Enstrom and I encountered when we published our BMJ paper. Critics were outraged by the article and demanded its retraction. But they were never able to satisfactorily explain why such an extreme step was justified.

Keep reading

New paper shows COVID boosters increased mortality in nursing home residents. The effect was highly statistically significant after 4 weeks.

A new paper by Girma and Paton showed by using machine learning a small but dubious (and short lived) benefit for nursing home residents in 2 of 3 metrics. In other words, they couldn’t find a definitive benefit for the primary series and they found NO benefit for additional shots.

In fact, for the boosters, they found a highly statistically significant INCREASE in COVID mortality after the boosters were administered.

We should only be giving these shots if there is a clear and significant benefit, not “we aren’t sure” or “there is no benefit.” But when there is a highly statistically significant harm, alarm bells should go off!

The paper says, “Indeed, in the later period, we find some evidence that higher vaccination rates are associated with higher Covid mortality.” A safe and effective vaccine shouldn’t be even close to causing a conclusion like that.

Additionally, vaccinating the nursing home staff also appeared to have a negative impact on residents. There, the impact on both COVID deaths and all-cause deaths was 100% consistent in all 7 time periods and for each vaccine dose: it always made things worse, and for the primary series where every single one of the 14 measures were highly statistically significant (99% confident).

This is yet another paper showing continuation of COVID vaccination is nonsensical. But the data doesn’t seem to matter and nobody wants to talk about it.

As usual, expect the mainstream media to ignore this paper as they do for any paper that shows that the health interventions were detrimental.

Keep reading

‘Should Not Be Used in Any Infants’: Higher Death Risk in Beyfortus RSV Shot Clinical Trials

Infants treated for RSV with the monoclonal antibody nirsevimab have significantly higher mortality rates than those treated with a different monoclonal antibody or with a placebo, according to an analysis by the Japanese journal Med Check of three major randomized control trials.

The report reanalyzed clinical trial data showing that nirsevimab — marketed by Sanofi and AstraZeneca as Beyfortus — reduced RSV-associated lower respiratory tract infection and hospitalizations in both high-risk and healthy infants.

However, babies treated with the drug had a higher mortality rate likely linked to adverse effects — including thrombosis (blood clotting) — from the drug itself, the study found.

“Due to the increased mortality, nirsevimab should not be used in any infants,” the study concluded. “Do not use nirsevimab for universal immunization.”

Shortly after its approval by the European Medicines Association in October 2022, and fast-track approval by the U.S. Food and Drug Administration in July 2023, the U.S., France, Spain and Luxembourg launched universal Beyfortus infant immunization campaigns for the 2023-24 RSV season.

Med Check published its appraisal of the clinical trials shortly after France’s National Agency for the Safety of Medicines and Health Products (ANSM) published its first pharmacovigilance data on the drug, compiled during the 2023-24 season.

The ANSM report tracked adverse events related to Beyfortus in France between Sept. 11, 2023, and April 30, 2024. Of 244,495 doses delivered, 198 adverse events were reported to the pharmacovigilance system, of which 153 were considered serious.

The report identified safety signals for stroke, respiratory conditions and hypotonic-hyporesponsive episodes — when an infant suddenly loses muscle strength and becomes “floppy.” Hypotonic-hyporesponsive episodes also are associated with the diphtheria-tetanus-pertussis, or Tdap, vaccine and other vaccines.

There were also three reports of sudden infant death syndrome (SIDS), although researchers said at least one of them was likely not linked to the drug.

The ANSM said each of the signals would be closely monitored in the future, but that a causal link between Beyfortus and those adverse events had not yet been established. The agency concluded the results confirm that the benefits of using the drug to treat bronchiolitis, an RSV infection, outweigh the risks.

The ANSM continues to recommend all newborn babies receive the Beyfortus shot this RSV season.

Keep reading

Whistleblower: Remdesivir linked to 601 military deaths

A military whistleblower has released documents, known as “The Remdesivir Papers,” revealing that 601 military service members died after being treated with the controversial antiviral drug remdesivir for suspected COVID-19 cases. The documents claim the drug was administered months before it was approved by the FDA, with serious concerns about data manipulation and lack of informed consent in the trials.

The whistleblower, using the pseudonym Daniel LeMay, shared the documents with investigative journalist J.M. Phelps, exposing that many trial results were kept secret and highlighting remdesivir’s potential role in hundreds of untimely deaths. According to LeMay, the Department of Defense’s Joint Trauma System manipulated trial data to favor remdesivir, and participants were often not informed about the risks involved.

Advocacy groups and former victims of COVID-19 hospital protocols, including those involving remdesivir, have expressed outrage, calling for greater accountability. Gail Seiler, a survivor of remdesivir treatment, stated that the papers “only scratch the surface” of the harm caused by the drug in both military and civilian hospitals.

Keep reading

Whistleblower Serves Connecticut Officials Notice of Covid Vaccine Deaths

On August 21, 2024, John Beaudoin, Sr., President and CEO of Summa Logica LLC, filed a whistleblower complaint with the Auditors of Public Accounts of Connecticut. The allegations pertain to forgery of death records under Conn. Gen. Stat. § 53a-139 (2023). More than 100 Connecticut death records list “Covid” as a cause of death though the deaths are certified as “accidental” and involve blunt force trauma or fentanyl overdose. Other records were found to be Covid vaccine deaths, but the vaccine is fraudulently omitted from the death records.

The whistleblower complaint was accompanied by THE CONNECTICUT MEMORANDA SERIES Volume II (CT Memo Vol. II) comprising nearly 250 pages of factual allegations gleaned from Connecticut’s official vital records database of death records.

Four death records expressly state that a Covid vaccine was involved in the deaths. One boy 16 years old died due to “Stress Cardiomyopathy Following Second Dose of the Pfizer-BioNTech.” Dalcie, 73 years old, died from Guillain Barre Syndrome. Her record also states, “second Pfizer-BioNTech COVID-19 Vaccine 28 days before start of symptoms.” Juana, 39 years old, died from “Sudden Cardiac Death,” “Probable … myocarditis.” Juana’s record states that myocarditis resulted from Covid. This is odd because her record also states she was vaccinated for Covid. Myocarditis is known to occur from Covid vaccines, but not from Covid. Lorraine was 85 years old and died from congestive heart failure only two days after vaccination. Only the boy’s record lists “Y59.0,” which means, “Viral vaccines.” The other three records omit any code related to vaccines even though the records clearly state that a Covid vaccine was a cause or contributing condition of death.

The Centers for Disease Control and Prevention (CDC) uses software that reads the English words in the causes of death on the records and then automatically outputs the ICD-10 codes, which are international symptom diagnostic codes. “Y59.0” is an ICD-10 code. If “vaccination” or “vaccine” are on the death record and “Y59.0” is missing after the software executes, it is highly likely that someone deleted “Y59.0,” else someone manually added “Y59.0” for the boy and did not add “Y.59.0” for the other three.

Keep reading

‘Should Not Be Used in Any Infants’: Higher Death Risk in Beyfortus RSV Shot Clinical Trials

Infants treated for RSV with the monoclonal antibody nirsevimab have significantly higher mortality rates than those treated with a different monoclonal antibody or with a placebo, according to an analysis by the Japanese journal Med Check of three major randomized control trials.

The report reanalyzed clinical trial data showing that nirsevimab — marketed by Sanofi and AstraZeneca as Beyfortus — reduced RSV-associated lower respiratory tract infection and hospitalizations in both high-risk and healthy infants.

However, babies treated with the drug had a higher mortality rate likely linked to adverse effects — including thrombosis (blood clotting) — from the drug itself, the study found.

“Due to the increased mortality, nirsevimab should not be used in any infants,” the study concluded. “Do not use nirsevimab for universal immunization.”

Shortly after its approval by the European Medicines Association in October 2022, and fast-track approval by the U.S. Food and Drug Administration in July 2023, the U.S., France, Spain and Luxembourg launched universal Beyfortus infant immunization campaigns for the 2023-24 RSV season.

Med Check published its appraisal of the clinical trials shortly after France’s National Agency for the Safety of Medicines and Health Products (ANSM) published its first pharmacovigilance data on the drug, compiled during the 2023-24 season.

The ANSM report tracked adverse events related to Beyfortus in France between Sept. 11, 2023, and April 30, 2024. Of 244,495 doses delivered, 198 adverse events were reported to the pharmacovigilance system, of which 153 were considered serious.

The report identified safety signals for stroke, respiratory conditions and hypotonic-hyporesponsive episodes — when an infant suddenly loses muscle strength and becomes “floppy.” Hypotonic-hyporesponsive episodes also are associated with the diphtheria-tetanus-pertussis, or Tdap, vaccine and other vaccines.

There were also three reports of sudden infant death syndrome (SIDS), although researchers said at least one of them was likely not linked to the drug.

The ANSM said each of the signals would be closely monitored in the future, but that a causal link between Beyfortus and those adverse events had not yet been established. The agency concluded the results confirm that the benefits of using the drug to treat bronchiolitis, an RSV infection, outweigh the risks.

The ANSM continues to recommend all newborn babies receive the Beyfortus shot this RSV season.

Keep reading

Children who received mRNA Covid shots died SIX TIMES as often as unjabbed kids in a very large database

The study about Covid and asthma in American kids and teens has gone mostly unnoticed. It hasn’t been cited once since it was published in June.

Which may be why no one has raised an alarm over the stunning figures buried in its appendix about deaths among mRNA Covid-vaccinated kids.

They show that 354 of the 64,000 children and teenagers who received a Covid mRNA shot died within a year after vaccination – a death rate of almost six kids per 1,000.

In contrast, only 309 out of 320,000 unvaccinated kids died, fewer than one per 1,000.

Both the difference and the absolute death rates reported in the study are shockingly high.1 (Covid infections did not cause more deaths, the data show.)

Part, and possibly all, of the gap comes from the fact that jabbed kids were notably sicker than the unvaccinated when the study began. They had higher rates of diabetes, psychiatric disorders, and other conditions.

Keep reading

Sudden ‘Unexpected’ Infant Death Increased Post-Covid Shot Rollout — Study

A study published Thursday documented how sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased slightly during the Covid pandemic of 2020, after which a massive increase was documented following the Covid exotic technology injection rollout in 2021.

“In this cross-sectional study of 14,308 SUID cases, the risk of SUID and SIDS increased during the intrapandemic period (March 2020 to December 2021) compared with the prepandemic period (March 2018 to December 2019), with the greatest increases noted in 2021 (9% for SUID and 10% for SIDS). A marked statistically significant monthly increase in SUID from June to December 2021 was observed,” the study said in the ‘Findings’ section.

While there was an uptick in infant deaths beginning in July 2020, between June 2021 and December 2021 there was a massive increase of up to 14 percent. Notably, the lethal Covid injections generally rolled out around the start of 2021.

“Monthly assessments revealed an increased risk of SUID beyond the prepandemic baseline starting in July 2020, with a pronounced epidemiologic shift from June to December 2021 (ranging from 10% to 14%),” the study said in the ‘Results’ section.

The researchers defined these deadly syndromes as umbrella terms for dead babies. It should also be noted that there is now ‘post Covid vaccine syndrome‘.

“Sudden unexpected infant death is an umbrella term used to describe the sudden death of an infant younger than 1 year for whom the cause of death is not apparent prior to investigation. Deaths from sudden infant death syndrome (SIDS), which occur during sleep and remain unexplained after a thorough postmortem investigation, comprise more than one-third of SUID cases,” the study said in the ‘Introduction’ section.

Ironically, the researchers bypassed the elephant in the room and claimed that the cause of the 2021 increase came down to ‘altered infectious disease transmission’.

Keep reading

Respiratory therapist says thousands of COVID-19 patients died due to irrational rush to deploy ventilators

The rush to put COVID-19 patients on ventilators during the early days of the pandemic caused thousands of needless deaths, according to respiratory therapist Mark Bishofsky, who witnessed this phenomenon firsthand.

Speaking to Good Morning CHD, Bishofsky recounted how he personally saw hospital staff intubating numerous coronavirus patients prematurely while denying them other treatments that could have been effective and came with fewer risks.

“Many, many thousands of patients died because of this rush to early intubation and not allowing early treatment with medications like ivermectin and hydroxychloroquine or even vitamin D — they wouldn’t even give these patients vitamin D. They just wanted to intubate them and put them on remdesivir,” he said.

Mechanical ventilators work by pushing oxygen into people with failing lungs. They are first sedated before a tube is placed into their throat, and many people who received this intervention during the pandemic never recovered.

He also claimed that their rush to intubate patients went against typical protocol, with some people being intubated despite needing just a small amount of oxygen. For example, he saw people being intubated for needing just three liters of oxygen, which he said is something he hadn’t seen in 25 years of practice.

He explained: “That’s so little oxygen to the point where if you took the patient off of it, they’re gonna be fine.”

The respiratory therapist conceded that ventilators are a crucial tool for saving lives, but they can also be “extremely dangerous” given their propensity to cause bacterial pneumonia.

He said he spoke out at first, trying to convince doctors they were making a mistake. Intubation was always considered a last resort, he said, and the hospital didn’t seem to have a good explanation for why they were using it so much.

Keep reading

NHS Whistleblower: ‘We Were Instructed to Euthanize Patients to Inflate COVID Death Toll While Hospitals Sat Empty!’

An NHS whistleblower, who wishes to remain anonymous, has come forward with allegations that the NHS hospitals were not overwhelmed during the COVID-19 pandemic, as was reported by authorities and the mainstream media.

The whistleblower also confirmed that the little care given throughout the pandemic amounted to negligence and that the government and NHS bosses essentially instructed staff to let people die, or in some cases kill them through the ‘End of Life Care’ programme and falsely label the deaths as being due to Covid-19.

This individual referred to as Dr. John, has worked in minor injuries and illness centres as well as in a primary care role throughout the pandemic.

Dr. John claims that he has “seen this mess evolve from the very beginning of the pandemic” and that hospitals were actually extremely quiet and almost empty during the first lockdown.

“I used to see an average of 20 patients per day, that dropped to 1 – 2 patients during the first lockdown. I have even witnessed an elderly lady with horrific broken bones come into the hospital three weeks after her accident as she was too scared of catching coronavirus to visit the hospital sooner. In the end, the pain overcame the fear.

“I have also assessed people with chest pains in their homes who would not go for further assessment as they were so scared of ‘the virus’ they would rather chance a heart attack than the infection or the loneliness of going to the hospital alone.”

NHS statistics certainly back up Dr John’s claims.

Keep reading